Please assess the completion status of the following clinical trial:

Trial Title: Calcipotriol and Polymorphic Light Eruption

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of PLE either by typical history and/or typical histology of lesions and/or positive phototesting results~* Age \> 18 years~Exclusion Criteria:~* Presence of or history of malignant skin tumors~* Dysplastic melanocytic nevus syndrome~* Photosensitive diseases such as porphyria, chronic actinic dermatitis, Xeroderma pigmentosum, basal cell nevus syndrome, and others~* Autoimmune disorders such as Lupus erythematosus or dermatomyositis~* Psychiatric disorders~* Immune deficiency or systemic treatment with steroids and/or other immunosuppressive drugs~* Pregnancy or lactation~* Antinuclear antibodies~* UV exposure in test fields within 8 weeks before study start~* General poor health status~* Severe liver or renal disease, disorders or therapy of the calcium metabolism with vitamin D containing drugs

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).